Quantitative structure- enhancement relationship and the microenvironment of the enhancer site of action

Percutaneous Penetration Enhancers, Second Edition

Volumn , Issue , 2005, Pages 35-49

  Li, S Kevin ^a   Higuchi, William I ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057253909     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (29)

1. Anderson BD, Higuchi WI, Raykar PV, Heterogeneity effects on permeability-partition coefficient relationships in human stratum corneum, Pharm Res, 5, 566-573, 1988.
2. Anderson BD, Raykar PV, Solute structure-permeability relationships in human stratum corneum, J Invest Dermatol, 93, 280-286, 1989.
3. Aungst BJ, Structure/effect studies of fatty acid isomers as skin penetration enhancers and skin irritants, Pharm Res, 6, 244-247, 1989.
4. Aungst BJ, Rogers NJ, Shefter E, Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides, Int J Pharm, 33, 225-234, 1986.
5. Barry BW, Mode of action of penetration enhancers in human skin, J Control Release, 6, 85-97, 1987.
6. Brain KR, Walters KA, Molecular modeling of skin permeation enhancement by chemical agents, In: Pharmaceutical Skin Penetration Enhancement, Walters KA and Hadgraft J, Editors. 1993, New York: Marcel Dekker, p. 389-416.
7. Bouwstra JA, Pilgram GSK, Ponec M, Does the single gel phase exist in stratum corneum? J Invest Dermatol, 118, 897-898, 2002a.
8. Bouwstra JA, Gooris GS, Dubbelaar FER, Ponec M, Phase behavior of stratum corneum lipid mixtures based on human ceramides: the role of natural and synthetic ceramide 1, J Invest Dermatol, 118, 606-617, 2002b.
9. Chantasart D, Li SK, He N, Warner KS, Prakongpan S, Higuchi WI, Mechanistic studies of branchedchain alkanols as skin permeation enhancers, J Pharm Sci, 93, 762-779, 2004.
10. Cooper ER, Increased skin permeability for lipophilic molecules, J Pharm Sci, 73, 1153-1156, 1984.
11. Goates CY, Knutson K, Enhanced permeation of polar compounds through human epidermis. I. Permeability and membrane structural changes in the presence of short chain alcohols, Biochim Biophys Acta, 1195, 169-179, 1994.
12. He N, Li SK, Suhonen TM, Warner KS, Higuchi WI, Mechanistic study of alkyl azacycloheptanones as skin permeation enhancers by permeation and partition experiments with hairless mouse skin, J Pharm Sci, 92, 297-310, 2003.
13. He N, Warner KS, Chantasart D, Shaker DS, Higuchi WI, Li SK, Mechanistic study of chemical skin permeation enhancers with different polar and lipophilic functional groups, J Pharm Sci, 93, 1415-1430, 2004.
14. Kim YH, Ghanem AH, Mahmoud H, Higuchi WI, Short chain alkanols as transport enhancers for lipophilic and polar/ionic permeants in hairless mouse skin: mechanism(s) of action, Int J Pharm, 80, 17-31, 1992.
15. Kuempel D, Swartzendruber DC, Squier CA, Wertz P, In vitro reconstitution of stratum corneum lipid lamellae, Biochim Biophys Acta, 1372, 135-140, 1998.
16. Lee VHL, Yamamoto A, Kompelia UB, Mucosal penetration enhancers for facilitation of peptide and protein drug absorption, Crit Rev Ther Drug Carrier Syst, 8, 91-192, 1991.
17. Liu P, Higuchi WI, Ghanem A-H, Kurihara-Bergstrom T, Good WR, Assessing the influence of ethanol in simultaneous diffusion and metabolism of estradiol in hairless mouse skin for the ‘asymmetric’ situation in vitro, Int J Pharm, 78, 123-136, 1992.
18. Norlen L, Skin barrier structure and function: the single gel phase model, J Invest Dermatol, 117, 830-836, 2001.
19. Ogiso T, Iwaki M, Paku T, Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors, J Pharm Sci, 84, 482-488, 1995.
20. Potts RO, Guy RH, Mechanisms of Transdermal Drug Delivery. 1997, New York: Marcel Dekker.
21. Raykar PV, Fung MC, Anderson BD, The role of protein and lipid domains in the uptake of solutes by human stratum corneum, Pharm Res, 5, 140-150, 1988.
22. Smith EW, Maibach HI, Percutaneous Penetration Enhancers. 1995, Boca Raton: CRC Press, Inc.
23. Walters KA, Hadgraft J, Pharmaceutical Skin Penetration Enhancers. 1993, New York: Marcel Dekker.
24. Warner KS, Li SK, Higuchi WI, Influences of alkyl group chain length and polar head group on chemical skin permeation enhancement, J Pharm Sci, 90, 1143-1153, 2001.
25. Warner KS, Li SK, He N, Suhonen TM, Chantasart D, Bolikal D, Higuchi WI, Structure-activity relationship for chemical skin permeation enhancers: probing the chemical microenvironment of the site of action, J Pharm Sci, 92, 1305-1322, 2003.
26. White SH, Mirejovsky D, King GI, Structure of lamellar lipid domains and corneocyte envelopes of murine stratum corneum. An x-ray diffraction study, Biochemistry 27, 3725-3732, 1988.
27. Williams AC, Barry BW, Skin absorption enhancers. Crit Rev Ther Drug Carrier Syst, 9, 305-353, 1992.
28. Yoneto K, Ghanem AH, Higuchi WI, Peck KD, Li SK, Mechanistic studies of the 1-alkyl-2-pyrrolidones as skin permeation enhancers, J Pharm Sci, 84, 312-317, 1995.
29. Yoneto K, Li SK, Higuchi WI, Jiskoot W, Herron JN, Fluorescent probe studies of the interactions of 1-alkyl-2-pyrrolidones with stratum corneum lipid liposomes, J Pharm Sci, 85, 511-517, 1996.